Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 09-Oct-24 4:11 PM View:  | Bishop Hans Edgar Director | Sana Biotechnology, Inc. (SANA) | 07-Oct-24 | Grant | 5,938 | -- | -- | < 1% 5.78M to 5.79M | |
| 26-Sep-24 4:07 PM View: | Mulligan Richard Director | Sana Biotechnology, Inc. (SANA) | 25-Sep-24 | Sale (Planned) | 150,000 | $3.89 | $583,170.00 | (5%) 2.85M to 2.7M | |
| 26-Sep-24 4:07 PM View: | Mulligan Richard Director | Sana Biotechnology, Inc. (SANA) | 24-Sep-24 | Sale (Planned) | 150,000 | $4.08 | $612,570.00 | (5%) 3.0M to 2.85M | |
| 08-Jul-24 4:32 PM View: | Bishop Hans Edgar Director | Sana Biotechnology, Inc. (SANA) | 05-Jul-24 | Grant | 4,911 | -- | -- | < 1% 5.78M to 5.78M | |
| 08-Apr-24 4:51 PM View: | Bishop Hans Edgar Director | Sana Biotechnology, Inc. (SANA) | 05-Apr-24 | Grant | 2,774 | -- | -- | < 1% 5.78M to 5.78M | |
| 11-Mar-24 4:57 PM View: | Yang Patrick Y Director | Sana Biotechnology, Inc. (SANA) | 08-Mar-24 | Sale | 25,000 | $9.45 | $236,300.00 | (14%) 174.25K to 149.25K | |
| 12-Feb-24 5:43 PM View: | Arch Venture Fund X, L.P. 10% Owner | Sana Biotechnology, Inc. (SANA) | 08-Feb-24 | Private Purchase | 1,818,180 | $5.50 | $10,000,000.00 | 4% 44.04M to 45.86M | |
| 12-Feb-24 5:46 PM View: | Nelsen Robert Director 10% Owner | Sana Biotechnology, Inc. (SANA) | 08-Feb-24 | Private Purchase Duplicate | 1,818,180 | $5.50 | $10,000,000.00 | 4% 44.06M to 45.87M | |
| 12-Feb-24 5:43 PM View: | Crandell Keith 10% Owner | Sana Biotechnology, Inc. (SANA) | 08-Feb-24 | Private Purchase Duplicate | 1,818,180 | $5.50 | $10,000,000.00 | 4% 44.04M to 45.86M | |
| 08-Jan-24 5:38 PM View: | Bishop Hans Edgar Director | Sana Biotechnology, Inc. (SANA) | 05-Jan-24 | Grant | 4,901 | -- | -- | < 1% 5.77M to 5.78M | |
| 08-Jan-24 5:38 PM View: | Wilderotter Maggie Director | Sana Biotechnology, Inc. (SANA) | 05-Jan-24 | Grant | 1,470 | -- | -- | 26% 5.64K to 7.11K | |
| 18-Dec-23 4:51 PM View: | Hordo Christian EVP, Chief Business Officer | Sana Biotechnology, Inc. (SANA) | 15-Dec-23 | Sale (Planned) | 75,000 | $4.00 | $300,098.00 | (8%) 942.46K to 867.46K | |
| 06-Oct-23 4:20 PM View: | Wilderotter Maggie Director | Sana Biotechnology, Inc. (SANA) | 05-Oct-23 | Grant | 2,077 | -- | -- | 58% 3.56K to 5.64K | |
| 06-Oct-23 4:20 PM View: | Bishop Hans Edgar Director | Sana Biotechnology, Inc. (SANA) | 05-Oct-23 | Grant | 6,925 | -- | -- | < 1% 5.77M to 5.77M | |
| 15-Sep-23 7:00 PM View: | Flagship Pioneering Inc. 10% Owner | Sana Biotechnology, Inc. (SANA) | 13-Sep-23 | Disposition (other) | 11,781,300 | -- | -- | (32%) 37.36M to 25.58M | |
| 06-Jul-23 4:21 PM View: | Bishop Hans Edgar Director | Sana Biotechnology, Inc. (SANA) | 05-Jul-23 | Grant | 4,152 | -- | -- | < 1% 5.76M to 5.77M | |
| 06-Jul-23 4:21 PM View: | Wilderotter Maggie Director | Sana Biotechnology, Inc. (SANA) | 05-Jul-23 | Grant | 1,245 | -- | -- | 54% 2.31K to 3.56K | |
| 08-Jun-23 7:00 PM View: | Flagship Ventures Fund V Ge... 10% Owner | Sana Biotechnology, Inc. (SANA) | 07-Jun-23 | Sale | 200,000 | $6.24 | $1,247,940.00 | (< 1%) 33.49M to 33.29M | |
| 08-Jun-23 7:00 PM View: | Flagship Ventures Fund V Ge... 10% Owner | Sana Biotechnology, Inc. (SANA) | 06-Jun-23 | Sale | 203,758 | $6.31 | $1,284,920.00 | (< 1%) 33.69M to 33.49M | |
| 26-May-23 8:00 PM View: | Flagship Ventures Fund V Ge... 10% Owner | Sana Biotechnology, Inc. (SANA) | 26-May-23 | Sale | 82,000 | $6.23 | $510,573.00 | (< 1%) 33.78M to 33.69M | |
| 26-May-23 8:00 PM View: | Flagship Ventures Fund V Ge... 10% Owner | Sana Biotechnology, Inc. (SANA) | 25-May-23 | Sale | 115,372 | $6.35 | $732,866.00 | (< 1%) 33.89M to 33.78M | |
| 26-May-23 8:00 PM View: | Flagship Ventures Fund V Ge... 10% Owner | Sana Biotechnology, Inc. (SANA) | 24-May-23 | Sale | 347,870 | $6.57 | $2,283,840.00 | (1%) 34.24M to 33.89M | |
| 06-Apr-23 4:45 PM View: | Bishop Hans Edgar Director | Sana Biotechnology, Inc. (SANA) | 05-Apr-23 | Grant | 7,716 | -- | -- | < 1% 5.75M to 5.76M | |
| 06-Apr-23 4:46 PM View: | Wilderotter Maggie Director | Sana Biotechnology, Inc. (SANA) | 05-Apr-23 | Grant | 2,314 | -- | -- | 100% 0 to 2.31K | |
| 06-Jan-23 4:19 PM View: | Nelsen Robert Director 10% Owner | Sana Biotechnology, Inc. (SANA) | 05-Jan-23 | Grant | 536 | -- | -- | < 1% 44.06M to 44.06M | |
| 06-Jan-23 4:17 PM View: | Bishop Hans Edgar Director | Sana Biotechnology, Inc. (SANA) | 05-Jan-23 | Grant | 6,702 | -- | -- | < 1% 5.75M to 5.75M | |
| 06-Oct-22 4:05 PM View: | Bishop Hans Edgar Director | Sana Biotechnology, Inc. (SANA) | 05-Oct-22 | Grant | 4,012 | -- | -- | < 1% 5.74M to 5.75M | |
| 06-Oct-22 4:06 PM View: | Nelsen Robert Director 10% Owner | Sana Biotechnology, Inc. (SANA) | 05-Oct-22 | Grant | 321 | -- | -- | < 1% 44.06M to 44.06M | |
| 07-Jul-22 4:30 PM View: | Nelsen Robert Director | Sana Biotechnology, Inc. (SANA) | 05-Jul-22 | Grant | 266 | -- | -- | < 1% 44.06M to 44.06M | |
| 07-Jul-22 4:32 PM View: | Bishop Hans Edgar Director | Sana Biotechnology, Inc. (SANA) | 05-Jul-22 | Grant | 3,328 | -- | -- | < 1% 5.74M to 5.74M | |
| 15-Jun-22 6:16 PM View: | MacDonald James J. EVP & General Counsel | Sana Biotechnology, Inc. (SANA) | 13-Jun-22 | Option Exercise | 66,796 | $1.48 | $98,858.10 | 10% 688.41K to 755.21K | |
| 15-Jun-22 6:16 PM View: | MacDonald James J. EVP & General Counsel | Sana Biotechnology, Inc. (SANA) | 13-May-22 | Grant | 1,183 | $4.28 | $5,067.97 | < 1% 687.23K to 688.41K | |
| 06-Apr-22 5:55 PM View: | Bishop Hans Edgar Director | Sana Biotechnology, Inc. (SANA) | 05-Apr-22 | Grant | 2,880 | -- | -- | < 1% 5.74M to 5.74M | |
| 06-Apr-22 5:54 PM View: | Nelsen Robert Director | Sana Biotechnology, Inc. (SANA) | 05-Apr-22 | Grant | 230 | -- | -- | < 1% 44.05M to 44.06M | |
| 22-Mar-22 7:51 PM View: | Yang Patrick Y Director | Sana Biotechnology, Inc. (SANA) | 21-Mar-22 | Private Purchase | 28,000 | $7.30 | $204,400.00 | 19% 146.25K to 174.25K | |
| 23-Feb-22 5:01 PM View: | MacDonald James J. EVP & General Counsel | Sana Biotechnology, Inc. (SANA) | 18-Feb-22 | Sale (Planned) | 333 | $6.28 | $2,091.24 | (< 1%) 687.56K to 687.23K | |
| 23-Feb-22 5:01 PM View: | MacDonald James J. EVP & General Counsel | Sana Biotechnology, Inc. (SANA) | 15-Nov-21 | Grant | 1,000 | $18.23 | $18,232.50 | < 1% 686.56K to 687.56K | |
| 17-Sep-21 4:27 PM View: | Agarwal Sunil EVP, Head of Development & CMO | Sana Biotechnology, Inc. (SANA) | 16-Sep-21 | Market Sale (Planned) | 1,627 | $26.00 | $42,302.00 | (< 1%) 1.55M to 1.55M | 1% |
| 17-Sep-21 4:27 PM View: | Agarwal Sunil EVP, Head of Development & CMO | Sana Biotechnology, Inc. (SANA) | 15-Sep-21 | Market Sale (Planned) | 58,373 | $26.07 | $1,521,750.00 | (4%) 1.61M to 1.55M | 1% |
| 10-Sep-21 7:27 PM View: | Hordo Christian EVP, Chief Business Officer | Sana Biotechnology, Inc. (SANA) | 09-Sep-21 | Market Option Sale (Planned) | 39,205 | $25.01 | $980,559.00 | (4%) 1.01M to 969.4K | |
| 10-Sep-21 7:27 PM View: | Hordo Christian EVP, Chief Business Officer | Sana Biotechnology, Inc. (SANA) | 09-Sep-21 | Option Exercise | 39,205 | $1.48 | $58,023.40 | 4% 969.39K to 1.01M | |
| 10-Sep-21 7:27 PM View: | Hordo Christian EVP, Chief Business Officer | Sana Biotechnology, Inc. (SANA) | 09-Sep-21 | Market Sale (Planned) | 25,466 | $25.01 | $636,932.00 | (3%) 969.4K to 943.93K | |
| 07-Sep-21 7:29 PM View: | Hordo Christian EVP, Chief Business Officer | Sana Biotechnology, Inc. (SANA) | 03-Sep-21 | Market Sale (Planned) | 700 | $25.00 | $17,500.00 | (< 1%) 970.1K to 969.4K | |
| 07-Sep-21 7:29 PM View: | Hordo Christian EVP, Chief Business Officer | Sana Biotechnology, Inc. (SANA) | 03-Sep-21 | Option Exercise | 700 | $1.48 | $1,036.00 | < 1% 969.4K to 970.1K | |
| 07-Sep-21 7:29 PM View: | Hordo Christian EVP, Chief Business Officer | Sana Biotechnology, Inc. (SANA) | 02-Sep-21 | Option Exercise | 6,558 | $1.48 | $9,705.84 | < 1% 970.8K to 977.36K | |
| 07-Sep-21 7:29 PM View: | Hordo Christian EVP, Chief Business Officer | Sana Biotechnology, Inc. (SANA) | 02-Sep-21 | Market Option Sale (Planned) | 7,258 | $25.00 | $181,466.00 | (< 1%) 977.36K to 970.1K | |
| 07-Sep-21 7:29 PM View: | Hordo Christian EVP, Chief Business Officer | Sana Biotechnology, Inc. (SANA) | 02-Sep-21 | Market Sale (Planned) | 700 | $25.00 | $17,501.60 | (< 1%) 970.1K to 969.4K | |
| 03-Sep-21 4:12 PM View: | Hordo Christian EVP, Chief Business Officer | Sana Biotechnology, Inc. (SANA) | 01-Sep-21 | Market Sale (Planned) | 3,002 | $25.01 | $75,065.40 | (< 1%) 973.8K to 970.8K | |
| 03-Sep-21 4:12 PM View: | Hordo Christian EVP, Chief Business Officer | Sana Biotechnology, Inc. (SANA) | 01-Sep-21 | Option Exercise | 1,134 | $1.48 | $1,678.32 | < 1% 973.8K to 974.93K | |
| 03-Sep-21 4:12 PM View: | Hordo Christian EVP, Chief Business Officer | Sana Biotechnology, Inc. (SANA) | 01-Sep-21 | Market Option Sale (Planned) | 1,134 | $25.01 | $28,355.80 | (< 1%) 974.93K to 973.8K |
